Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12608000029392Phase 3Recruiting
Phase 3, randomised, double-blind trial in chronic prostatitis (CP) and dysmenorrhea comparing Mirena intrauterine system insertion with Placebo intrauterine system insertion (2 arms). Primary endpoints: Daily ratings of dysmenorrhoea and Daily ratings of pelvic pain. Started Oct 2009; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12608000029392.